RecruitingNot applicableNCT06136611
Preoperative Preradiotherapy TTFields
Studying Giant cell glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Christie NHS Foundation Trust
- Intervention
- TTFields(device)
- Enrollment
- 42 enrolled
- Eligibility
- 35 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- The Christie NHS Foundation Trust, Manchester, United Kingdom
Collaborators
University of Manchester · Northern Care Alliance NHS Foundation Trust · NovoCure Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06136611 on ClinicalTrials.govOther trials for Giant cell glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07544992Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade GliomasCity of Hope Medical Center
- RECRUITINGEARLY PHASE1NCT07268053A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain MetastasesNader Sanai
- RECRUITINGPHASE2NCT07511725Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk GlioblastomaSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE3NCT07195591Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareGT Medical Technologies, Inc.
- RECRUITINGPHASE2NCT07263438Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialCentre Hospitalier Universitaire Vaudois
- RECRUITINGPHASE1NCT06176066PH Sensitive MRI Based Resections of GlioblastomaUniversity of California, Los Angeles
- RECRUITINGNANCT07121842Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRIErasmus Medical Center
- RECRUITINGNANCT06001281Predictive Value of Soluble CD146 in Glioblastoma PatientsAssistance Publique Hopitaux De Marseille